|
1
|
|
|
2
|
- Prehospital care is usually supportive
- Three complications that require intervention:
- Hypertensive disorders of pregnancy
- Severe vaginal bleeding
- Preterm labor
|
|
3
|
|
|
4
|
|
|
5
|
- Hormone and uterine stimulant
|
|
6
|
- Naturally occurring hormone that is secreted by the posterior pituitary
|
|
7
|
- Causes contraction of uterine smooth muscle and lactation
- Induces labor in selected cases
- Induces uterine contractions following delivery
- Thereby controlling postpartum hemorrhage
|
|
8
|
- Onset
- Immediate (IV), 3-7 minutes (IM)
- Peak effects
- Duration
- 1 hour (IV), 2-3 hours (IM)
- Half-life
|
|
9
|
|
|
10
|
- Only administered to patients suffering severe postpartum bleeding
- Verify the baby and placenta have been delivered and that there is not
an additional fetus in the uterus
|
|
11
|
- Excess oxytocin can cause over-stimulation of the uterus and possible
uterine rupture.
- Vital signs and uterine tone should be monitored.
|
|
12
|
- In the mother:
- Hypotension
- Dysrhythmias
- Tachycardia
- Seizures
- Coma
- Nausea and vomiting
- May have ADH effects at higher doses
- Water retention
- Vasoconstriction
|
|
13
|
- If given prior to delivery, in the fetus:
- Fetal hypoxia
- Fetal asphyxia
- Fetal arrhythmias
- Fetal intracranial bleeding
|
|
14
|
- Can cause hypertension when administered in conjunction with
vasoconstrictors such as norepinephrine
|
|
15
|
- Two different regimens in the management of postpartum hemorrhage
- Method 1:
- 3-10 units IM after delivery of the placenta
- Method 2:
- 10-20 units in 500 or 1000 mL of any solution
- Titrated to the severity of the bleeding and the uterine response
|
|
16
|
|
|
17
|
- Formerly called “toxemia of pregnancy”
- Characterized by:
- Hypertension
- Weight gain
- Edema
- Protein in the urine
- In late stages, seizure
|
|
18
|
- Gestational hypertension (GH)
- Blood pressure of 140/90 level or greater
- Patient who was previously normotensive
- Preeclampsia
- Hypertension, abnormal weight gain, edema, headache, and visual
disturbances
- If untreated, may progress to eclampsia
|
|
19
|
- Eclampsia
- Most serious of the hypertensive disorders
- Characterized by grand mal seizure activity
- Often preceded by visual disturbances
- Can be distinguished from epilepsy by the history and physical exam
|
|
20
|
|
|
21
|
|
|
22
|
- A salt that dissociates into the magnesium cation (Mg2+) and
the sulfate anion when administered
- Magnesium is an essential element in numerous biochemical reactions that
occur within the body.
|
|
23
|
- Central nervous system depressant effective in the management of
seizures associated with eclampsia
- After cessation of seizure activity, other anticonvulsant agents may be
used
|
|
24
|
- Onset
- Immediate (IV), 1 hour (IM)
- Peak effects
- Duration
- Half-life
|
|
25
|
|
|
26
|
- Patients who are in shock
- Persistent, severe hypertension
- Third-degree atrioventricular (AV) block
- Patients who routinely undergo dialysis
- Known decreased calcium levels
|
|
27
|
- Administer slowly to minimize side effects
- Use continuous cardiac monitoring
- Calcium salts should be available as an antidote for magnesium sulfate
in case serious side effects occur.
|
|
28
|
- Flushing
- Sweating
- Bradycardia
- Decreased deep tendon reflexes
- Drowsiness
- Respiratory depression
- Dysrhythmias
- Hypotension
- Hypothermia
- Itching and rash
|
|
29
|
- Can cause cardiac conduction abnormalities if administered in
conjunction with digitalis
|
|
30
|
- 2-4 g slow IV over 25 minutes
- If an IV cannot be started, administer IM
- Dose should be divided in half
- Each half administered intramuscularly at a separate site (usually each
gluteus)
|
|
31
|
|
|
32
|
- Labor that begins before the age of fetal maturity
- Usually before 36 weeks
- Often suppressed to allow more time for intrauterine fetal development
|
|
33
|
- Three approaches to suppression:
- Sedate the mother
- Administration of a fluid bolus
- 1-2 L of lactated Ringer’s
- Administration of tocolytics
- β2-agonists frequently used
- Causes uterine relaxation
|
|
34
|
|
|
35
|
- Sympathetic agonist and tocolytic
|
|
36
|
- A synthetic sympathomimetic that is selective for β2-adrenergic
receptors
|
|
37
|
- Causes immediate bronchodilation with minimal cardiac effects
- Stimulation of β2-adrenergic receptors in the uterus
causes uterine relaxation and can suppress labor.
|
|
38
|
- Onset
- Peak effects
- Duration
- Half-life
|
|
39
|
|
|
40
|
- Known history of hypersensitivity
|
|
41
|
- Caution should be used with:
- Elderly patients
- Cardiovascular disease
- Hypertension
- V/S must be monitored
|
|
42
|
- Palpitations
- Anxiety
- Dizziness
- Headache
- Nervousness
- Tremor
- Hypertension
- Dysrhythmias
- Chest pain
- Nausea and vomiting
|
|
43
|
- Unpleasant side effects increase when used with other sympathetic
agonists
- β-blockers may blunt the pharmacological effects of terbutaline
|
|
44
|
- Initial dose should be 0.25 mg SC
- Can be repeated in 30-60 minutes
- Maintenance drip can be used
- Placing 5 mg in 500 mL of lactated Ringer’s solution or normal saline
- 30 mL/hr (5 mg/min)
- Can be slowly increased to a maximum dose of 80 mg/min
|
|
45
|
|